Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-06

Clinical Trial Update: Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients [NA]

View source ↗

Summary

The document is a completed clinical trial update examining salmeterol's effect on alveolar-capillary fluid clearance in COPD patients; results are not provided…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmeterol (salmeterol)

Snippet

Sponsor: University of Milan | Conditions: Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients, Chronic Obstructive Pulmonary Disease | NA | Status: COMPLETED